Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Hoffmann-La Roche
Imugene Limited
Opna Bio LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Tracon Pharmaceuticals Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University of Chicago
Pfizer